Phibro Animal Health Corporation (PAHC)

Gross profit margin

		Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020
Gross profit (ttm)	US$ in thousands	399,942	376,711	351,015	327,761	311,966	301,854	298,522	297,291	298,237	300,071	296,157	289,444	285,476	276,776	274,315	271,908	271,349	262,149	262,535	263,374
Revenue (ttm)	US$ in thousands	1,296,215	1,190,682	1,106,080	1,046,762	1,017,630	999,515	981,965	976,668	977,889	978,140	972,086	960,152	942,296	907,296	879,406	852,843	833,372	798,972	797,982	805,845
Gross profit margin		30.85%	31.64%	31.74%	31.31%	30.66%	30.20%	30.40%	30.44%	30.50%	30.68%	30.47%	30.15%	30.30%	30.51%	31.19%	31.88%	32.56%	32.81%	32.90%	32.68%

June 30, 2025 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $399,942K ÷ $1,296,215K
= 30.85%

The gross profit margin of Phibro Animal Health Corporation has demonstrated a relatively stable performance over the examined period, with values generally oscillating between approximately 30% and 33%. From September 30, 2020, to December 31, 2021, the margin experienced a gradual decline, decreasing from 32.68% to 31.19%, indicating a marginal reduction in profitability relative to gross sales. This downward trend persisted into early 2022, with the margin reaching a low of approximately 30.15% on September 30, 2022.

Subsequently, a modest reversal occurred, with a slight increase in the gross profit margin beginning in late 2022 through early 2023, reaching around 30.68% on March 31, 2023. From this point onward, the margin maintained a narrow range close to 30.4% to 30.7%. Notably, in the fiscal year ending March 31, 2024, a minor uptick to 30.66% was observed, followed by an increase to approximately 31.31% on September 30, 2024, and further to 31.74% on December 31, 2024, representing a recovery to higher profitability levels within the observed period.

Looking ahead, projections indicate a slight decline to around 31.64% on March 31, 2025, with a subsequent decrease to approximately 30.85% by June 30, 2025. Overall, the gross profit margin has exhibited minor fluctuations but has largely remained within the 30% to 33% range, reflecting a relatively stable gross profitability profile with periods of slight contraction and recovery.